XML 48 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

Compensation costs for the years ended December 31, 2024 and 2023 was estimated for stock options based on the grant date fair value using a Black-Scholes option valuation model, consistent with authoritative guidance utilizing the following assumptions:

    

Years Ended December 31,

 

    

2024

    

2023

 

Expected volatility

79.67

%  

75.63% - 78.47

%

Expected dividend yield

0

%  

0

%

Risk-free interest rate

4.08

%  

3.64% – 4.87

%

Expected term

6.3

years

6.3

years

Schedule of Options Activity

A summary of the stock option award activity during the year ended December 31, 2024 is as follows:

    

    

    

Weighted Average

Remaining 

Number of

Weighted Average

Contractual Life 

Shares

Exercise Price

(in years)

Class A common stock awards outstanding at January 1, 2024

 

11,426,653

$

1.59

 

8.47

Granted

 

351,717

 

4.37

 

  

Exercised

 

(2,256,157)

 

0.46

 

  

Forfeited

 

(51,831)

 

3.18

 

  

Class A common stock awards outstanding at December 31, 2024

 

9,470,382

 

1.95

 

7.91

Class A common stock awards exercisable at December 31, 2024

 

3,256,613

 

1.29

 

6.96

Class A common stock awards not vested at December 31, 2024

 

6,213,769

 

  

 

  

Schedule of Restricted Stock Unit Award Activity

A summary of restricted stock unit award activity during the year ended December 31, 2024 is as follows:

Weighted Average

Number of Units

Grant Date Fair

    

Unvested

    

Vested

    

Value

Restricted stock units, beginning balance

 

 

 

Granted

 

1,390,298

 

 

8.02

Vested

 

(134,832)

 

134,832

 

7.78

Forfeited

 

(3,300)

 

 

7.46

Restricted stock units outstanding at December 31, 2024

 

1,252,166

 

134,832

 

8.02

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense charged to operations is summarized as follows:

    

Years Ended December 31,

2024

    

2023

Research and development

$

7,797

$

398

General and administrative

 

4,687

 

379

Total costs charged to operations (1)

$

12,484

$

777

(1)Year ended December 31, 2024 includes $7,784 of incremental costs of the modification of Legacy Oklos awards for the vested options-holders contingent right to receive a pro rata share of the Earnout Shares recorded at the Closing.